Canadian Pediatricians' Prescribing Practices for Community-Acquired Pneumonia
- 15 May 2013
- journal article
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 53 (5), 493-496
- https://doi.org/10.1177/0009922813488651
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Pneumonia in healthy Canadian children and youth: Practice points for managementPaediatrics & Child Health, 2011
- Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United StatesAntimicrobial Agents and Chemotherapy, 2010
- Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005International Journal of Antimicrobial Agents, 2009
- Increase in Pneumococcus Macrolide Resistance, United StatesEmerging Infectious Diseases, 2009
- The antimicrobial resistance profile of Streptococcus pneumoniaeClinical Microbiology & Infection, 2009
- Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibioticsJournal of Antimicrobial Chemotherapy, 2009
- The burden of pneumonia in children in the developed worldPaediatric Respiratory Reviews, 2005
- Community-Acquired Pneumonia in ChildrenNew England Journal of Medicine, 2002